Search Results - Louie-Gao, Melinda

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Increased risk of brain metastases in ovarian cancer patients with BRCA mutations

    Increased risk of brain metastases in ovarian cancer patients with BRCA mutations by Ratner, Elena, Bala, Mohan, Louie-Gao, Melinda, Aydin, Ebru, Hazard, Sebastien, Brastianos, Priscilla K.

    Published in Gynecologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis

    Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis by Reiter, Andreas, Gotlib, Jason, Álvarez-Twose, Iván, Radia, Deepti H., Lübke, Johannes, Bobbili, Priyanka J., Wang, Aolin, Norregaard, Chelsea, Dimitrijevic, Saša, Sullivan, Erin, Louie-Gao, Melinda, Schwaab, Juliana, Galinsky, Ilene A., Perkins, Cecelia, Sperr, Wolfgang R., Sriskandarajah, Priya, Chin, Andi, Sendhil, Selvam R., Duh, Mei Sheng, Valent, Peter, DeAngelo, Daniel J.

    Published in Leukemia
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Risk factors for progression or death after first-line platinum-based chemotherapy in real-world patients in the USA with ovarian cancer from 2011 to 2018

    Risk factors for progression or death after first-line platinum-based chemotherapy in real-world patients in the USA with ovarian cancer from 2011 to 2018 by Westin, Shannon N, Louie-Gao, Melinda, Gupta, Divya, Thaker, Premal H

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract P230: A phase 1/2 study of BLU-945, a highly potent and selective inhibitor of epidermal growth factor receptor (EGFR) resistance mutations, in patients with EGFR -mutant non-small cell lung cancer (NSCLC)

    Abstract P230: A phase 1/2 study of BLU-945, a highly potent and selective inhibitor of epidermal growth factor receptor (EGFR) resistance mutations, in patients with EGFR -mutant... by Spigel, David, Goto, Koichi, Camidge, D. Ross, Elamin, Yasir, de Langen, Adrianus J., Leighl, Natasha B., Minchom, Anna, Piotrowska, Zofia, Planchard, David, Reckamp, Karen, Albayya, Faris, Green, Jennifer, Kim, Sean, Louie-Gao, Melinda, Sawtell, Renata, Zalutskaya, Alena, Co, Byoung Chul

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Abstract CT157: An open-label Phase II study of combination of TSR-042, bevacizumab, and niraparib in patients with platinum-resistant ovarian cancer (OC): Cohort A of the OPAL trial

    Abstract CT157: An open-label Phase II study of combination of TSR-042, bevacizumab, and niraparib in patients with platinum-resistant ovarian cancer (OC): Cohort A of the OPAL tri... by Liu, Joyce, Gunderson, Camille, Hendrickson, Andrea Wahner, Ratner, Elena, Diver, Elisabeth, Moroney, John, Arend, Rebecca C., Louie-Gao, Melinda, Wang, Sarah, Luptakova, Katarina, Konecny, Gottfried E.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    MPN-435 Overall Survival in Patients With Systemic Mastocytosis With Associated Hematologic Neoplasm Treated With Avapritinib Versus Best Available Therapy

    MPN-435 Overall Survival in Patients With Systemic Mastocytosis With Associated Hematologic Neoplasm Treated With Avapritinib Versus Best Available Therapy by Reiter, Andreas, Gotlib, Jason, Álvarez-Twose, Iván, Radia, Deepti, Lübke, Johannes, ScD, Priyanka Bobbili, Wang, Aolin, Norregaard, Chelsea, Dimitrijević, Saša, Sullivan, Erin, Louie-Gao, Melinda, Schwaab, Juliana, Galinsky, Ilene, Perkins, Cecelia, Sperr, Wolfgang, Sriskandarajah, Priya, Chin, Andi, Sendhil, Selvam, ScD, Mei Sheng Duh, Valent, Peter, DeAngelo, Daniel

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Poster: MPN-435 Overall Survival in PatientsWith Systemic Mastocytosis With Associated Hematologic Neoplasm Treated With Avapritinib Versus Best Available Therapy

    Poster: MPN-435 Overall Survival in PatientsWith Systemic Mastocytosis With Associated Hematologic Neoplasm Treated With Avapritinib Versus Best Available Therapy by Reiter, Andreas, Gotlib, Jason, Álvarez-Twose, Iván, Radia, Deepti, Lübke, Johannes, ScD, Priyanka Bobbili, Wang, Aolin, Norregaard, Chelsea, Dimitrijević, Saša, Sullivan, Erin, Louie-Gao, Melinda, Schwaab, Juliana, Galinsky, Ilene, Perkins, Cecelia, Sperr, Wolfgang, Sriskandarajah, Priya, Chin, Andi, Sendhil, Selvam, ScD, Mei Sheng Duh, Valent, Peter, DeAngelo, Daniel

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract CT184: Emerging evidence of activity of BLU-945 in patients with advanced EGFR-mutant NSCLC utilizing circulating tumor DNA (ctDNA) in the phase 1/2 SYMPHONY study

    Abstract CT184: Emerging evidence of activity of BLU-945 in patients with advanced EGFR-mutant NSCLC utilizing circulating tumor DNA (ctDNA) in the phase 1/2 SYMPHONY study by Shum, Elaine, Elamin, Yasir, Reckamp, Karen L., Piotrowska, Zofia, Rotow, Julia, Tan, Daniel S., Goto, Koichi, Parepally, Jagan, Albayya, Faris, Louie-Gao, Melinda, Sawtell, Renata, Zalutskaya, Alena, Spigel, David

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: